Hence, we speculated that inhibition of MZF1 can serve as an efficient therapy to prevent CRC progression, and the kinase GSK3β may inhibit the expression of FTO and MZF1, thus functioning as a suppressor of CRC. This evidence concerns the gene GSK3B and colorectal carcinoma.